Literature DB >> 7913722

Photopsia during 3-hour paclitaxel administration at doses > or = 250 mg/m2.

A D Seidman, S Barrett, S Canezo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7913722     DOI： 10.1200/JCO.1994.12.8.1741

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.

Authors:  Carla C P Verstappen; Jan J Heimans; Klaas Hoekman; Tjeerd J Postma
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Visual evoked potentials findings in course of paclitaxel doxorubicin combination chemotherapy. Report of a case.

Authors:  V Scaioli; A Caraceni; C Martini; E Palazzini; E Tarenzi; F Fulfaro; E Munzone
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report.

Authors:  Thomas P Moloney; Wen Xu; Kristopher Rallah-Baker; Niara Oliveira; Natasha Woodward; Jonathon J Farrah
Journal:  BMC Ophthalmol       Date:  2014-02-24       Impact factor: 2.209

4.  Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review.

Authors:  Ying Li; Yanping Li; Junyu Li; Guoliang Pi; Wenyong Tan
Journal:  Onco Targets Ther       Date:  2014-07-31       Impact factor: 4.147

Review 5.  Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.

Authors:  Minas Sakellakis; Nikolaos Spathas; Konstantinos T Tsaousis; Emmanouil N Nikitiadis; Helena Linardou; Vasilios F Diakonis
Journal:  Cureus       Date:  2022-07-26

6.  Tamoxifen retinopathy: a case report.

Authors:  Lingling Wang; Heng Miao; Xiaoxin Li
Journal:  Springerplus       Date:  2015-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.